Successful long-term use of intravenous immunoglobulin to treat livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity

Papapit TuchindaAntonella TammaroAnthony A. GaspariUniversity of Maryland, BaltimoreMahidol UniversityUniversita degli Studi di Roma La Sapienza2018-05-032018-05-032011-10-01Archives of Dermatology. Vol.147, No.10 (2011), 1224-1225153836520003987X2-s2.0-80054775045https://repository.li.mahidol.ac.th/handle/20.500.14594/12303Mahidol UniversityMedicineSuccessful long-term use of intravenous immunoglobulin to treat livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosityNoteSCOPUS10.1001/archdermatol.2011.274